Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Effects on Postprandial Lipoproteins in Men With Type 2 Diabetes
NCT00660075Phase 3Completed
- Sponsor
- Université Laval
- Start
- Feb 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and postprandial lipemia comparing Sitagliptin with Placebo (2 arms). Primary endpoint: Area Under the Curve of Plasma Triglycerides at 8 hours. Started Feb 2008; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)postprandial lipemia
Beyond the preview
Go deeper on NCT00660075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660075.